Description

This research service identifies the major industry challenges, technology and market trends, market drivers and restraints, regulatory and consumer trends in the global curcumin 95% extract (as an ingredient) market. Value chain analysis and trends in value addition of curcumin ingredients are discussed. The study focuses on different end-application segments such as nutraceuticals, dietary supplements, and herbal in over-the-counter (OTC) pharmaceutical dosage forms (capsules, tablets, sachets), cosmetics, food and beverages, and other applications (photovoltaics, textile dyes).

The study also encompasses regional demand analysis for the North America, Europe, Asia-Pacific, and Rest of the World and competitive analyses. Market share analysis, competitive factors and assessment have been discussed at the total market level. Key market participants are Arjuna Natural Extracts, Sabinsa, OmniActive, Verdure Sciences, and Organica Aromatics.

Research Scope:
•     Market trends and strategic recommendations (personal care active ingredients)
•     Regional trends (North America, Europe, Asia-Pacific, and Rest of the World)
•     Analysis by segment and region has been provided with revenue forecasts for the period 2013–2023.

Key Questions this Study will Answer:
1.     What are the global growth prospects of curcumin 95% extracts, particularly in the nutraceuticals, food and beverages, cosmetics, and
other segments?
2.     What technology, pricing trends, and regulatory factors are observed in the market?
3.     What are the technology and market development strategies adopted for curcumin 95% by the leading suppliers?
4.     Are the products/services offered today meeting customer needs or is additional development needed?
5.     Are the participants in the space ready to go it alone, or do they need partnerships to take their businesses to the next level?

The total global curcumin market is expected to reach more than $100 million in 2023, growing at a CAGR of 12.6% from 2017 to 2023. Increased focus on R&D to enhance curcumin bioavailability is a major driver, with larger number of laboratory studies to prove structure-function relationships, and human clinical trials to establish efficacy and safety by specific applications (prevention and supportive treatment of digestive disorders, arthritis, cancers, cardiovascular diseases). Nutraceuticals (including dietary supplements and herbals) form more than 50% of the curcumin demand share, both by volume and revenue, and continue to grow faster than the other segments. The second-largest segment is food and beverages, growing slower than nutraceuticals and cosmetics. North America is the leading region in market size, while Europe leads market growth.